$VRTX

The National Plan for Epilepsy Act (S494) establishes a national strategy for epilepsy research and care. This bill directs federal agencies to coordinate efforts, potentially increasing funding for research and treatment development, benefiting pharmaceutical and biotechnology companies focused on neurological disorders.

The Immediate Access for the Terminally Ill Act accelerates patient access to experimental treatments, directly benefiting pharmaceutical and biotechnology companies developing late-stage therapies. This bill expands the market for investigational drugs, increasing revenue potential for companies with promising pipelines.

The Securing Infrastructure from Adversaries Act of 2025 (HR4802) will increase spending on cybersecurity and physical security for critical infrastructure, directly benefiting defense contractors and technology firms specializing in infrastructure protection. This bill creates new revenue streams for companies providing secure hardware and software solutions.